Lyell Immunopharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
23.4M
on 2026-06-30, from 12.7M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-20 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
1 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
6.1 quarters
$204.1M on 2026-06-30 ÷ $33.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-07-24 | Private placement | 3,753,752 | $13.32 | $50.0M | 8-K ↗ |
Also on file: a 1-for-20 reverse split, 2025-05-27 8-K ↗